icon- folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
San Francisco, CA
March 9-12 2025
 		Back grey_arrow_rt.gif
 
 
 
Proof-of-Concept Phase 2a Trial of VH4524184
(VH-184), a Third-Generation Integrase Strand Transfer Inhibitor
 
 
  CROI 2025 SF March 9-12

0312251

0312252

0312253

0312254

0312255

0312256